IL6 and myeloid sarcoma: The level of IL-6 was increased in pDCs from HDs in response to incubation with each of the MBP peptides, while after 12 h of incubation only GK16 and QR24 enhanced release of IL-6 by pDCs from MS patients by threefold to sixfold.